Our team is continually collaborating with customers, partners and fellow genomic experts to enhance our solutions and provide you with the best service possible
Enhanced & Automated Analysis (Autumn 2020)
Customers will be able to leverage their own curated variant databases to automate interpretation within the Congenica platform, allowing them to analyze, annotate and automate reporting in one place. We are also introducing additional predictive scores for improving analytic confidence, among other improvements.
Advanced automation and machine learning
Streamlining the pathogenicity classification of previously seen and unseen variants to compliment the platform’s existing automation and A.I. functionality and further reduce clinical interpretation and reporting times.
New speciality area applications
In addition to our existing suite of speciality area applications, we are continuing to develop genomic analysis solutions for targeted indications. In summer 2020, we’ll be releasing an expertly-curated solution for accelerating analysis of host viral susceptibility & response to COVID-19
Expanding beyond rare disease
We are actively exploring approaches to expand our clinical decision support platform to help laboratories analyze both germline and somatic variants. If you’re interested in collaborating or learning more, please get in touch.